Northern Trust’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.04M Buy
1,293,530
+92,330
+8% +$431K ﹤0.01% 2359
2025
Q1
$6.59M Buy
1,201,200
+4,819
+0.4% +$26.5K ﹤0.01% 2273
2024
Q4
$4.06M Buy
1,196,381
+38,155
+3% +$129K ﹤0.01% 2630
2024
Q3
$3.3M Buy
1,158,226
+51,057
+5% +$146K ﹤0.01% 2709
2024
Q2
$2.49M Sell
1,107,169
-52,386
-5% -$118K ﹤0.01% 2780
2024
Q1
$2.56M Sell
1,159,555
-5,808
-0.5% -$12.8K ﹤0.01% 2835
2023
Q4
$2.74M Buy
1,165,363
+20,146
+2% +$47.3K ﹤0.01% 2821
2023
Q3
$2.13M Sell
1,145,217
-8,566
-0.7% -$15.9K ﹤0.01% 2900
2023
Q2
$3.02M Buy
1,153,783
+44,206
+4% +$116K ﹤0.01% 2779
2023
Q1
$1.81M Buy
1,109,577
+13,205
+1% +$21.5K ﹤0.01% 2987
2022
Q4
$1.46M Buy
1,096,372
+1,749
+0.2% +$2.33K ﹤0.01% 3138
2022
Q3
$1.71M Sell
1,094,623
-10,311
-0.9% -$16.1K ﹤0.01% 3104
2022
Q2
$1.7M Buy
1,104,934
+898,486
+435% +$1.38M ﹤0.01% 3146
2022
Q1
$529K Buy
206,448
+16,426
+9% +$42.1K ﹤0.01% 3715
2021
Q4
$557K Buy
190,022
+67,263
+55% +$197K ﹤0.01% 3767
2021
Q3
$301K Sell
122,759
-4,179
-3% -$10.2K ﹤0.01% 3981
2021
Q2
$517K Sell
126,938
-365,760
-74% -$1.49M ﹤0.01% 3694
2021
Q1
$2.22M Buy
492,698
+5,342
+1% +$24.1K ﹤0.01% 3188
2020
Q4
$2.4M Sell
487,356
-22,688
-4% -$112K ﹤0.01% 3107
2020
Q3
$3.02M Buy
510,044
+99,891
+24% +$592K ﹤0.01% 2838
2020
Q2
$1.09M Buy
410,153
+11,304
+3% +$30.1K ﹤0.01% 3322
2020
Q1
$778K Buy
398,849
+96,675
+32% +$189K ﹤0.01% 3318
2019
Q4
$2.13M Sell
302,174
-3,674
-1% -$25.9K ﹤0.01% 3098
2019
Q3
$3.01M Buy
305,848
+56,634
+23% +$557K ﹤0.01% 2859
2019
Q2
$2.85M Buy
249,214
+9,188
+4% +$105K ﹤0.01% 2865
2019
Q1
$2.41M Buy
240,026
+165,603
+223% +$1.66M ﹤0.01% 2958
2018
Q4
$1.27M Buy
74,423
+1,089
+1% +$18.5K ﹤0.01% 3277
2018
Q3
$1.29M Buy
+73,334
New +$1.29M ﹤0.01% 3397